Cargando…

Molecular recognition requires dimerization of a VHH antibody

Camelid heavy-chain-only antibodies are a unique class of antibody that possesses only a single variable domain (termed VHH) for antigen recognition. Despite their apparent canonical mechanism of target recognition, where a single VHH domain binds a single target, an anti-caffeine VHH has been obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Christopher A., Sonneson, Gregory J., Hoey, Robert J., Hinerman, Jennifer M., Sheehy, Kimberly, Walter, Richard, Herr, Andrew B., Horn, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228392/ https://www.ncbi.nlm.nih.gov/pubmed/37243579 http://dx.doi.org/10.1080/19420862.2023.2215363

Ejemplares similares

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)

VHH Antibodies: Reagents for Mycotoxin Detection in Food Products
por: Wang, Jia, et al.
Publicado: (2018)

VHH-Based Bispecific Antibodies Targeting Cytokine Production
por: Nosenko, Maxim A., et al.
Publicado: (2017)

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
por: Lutje Hulsik, David, et al.
Publicado: (2013)

A Molecular Dynamics Simulation of the Human Lysozyme – Camelid VHH HL6 Antibody System
por: Su, Zhi-Yuan, et al.
Publicado: (2009)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
por: Weissenhorn, W, et al.
Publicado: (2012)

Use of VHH antibodies for the development of antigen detection test for visceral leishmaniasis
por: Abeijon, Claudia, et al.
Publicado: (2018)

Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
por: Pothin, Elodie, et al.
Publicado: (2020)

Recognition of Dimeric Lewis X by Anti-Dimeric Le(x) Antibody SH2
por: Jegatheeswaran, Sinthuja, et al.
Publicado: (2020)

VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
por: Low, Sarah, et al.
Publicado: (2020)

Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function
por: Tremblay, Jacqueline M., et al.
Publicado: (2020)

Search for Resonant and Non-Resonant VHH Production
por: Kyriacou, Nicholas Graves
Publicado: (2022)

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH
por: Emmerson, Chris D., et al.
Publicado: (2011)

Construction of a camelid VHH yeast two-hybrid library and the selection of VHH against haemagglutinin-neuraminidase protein of the Newcastle disease virus
por: Gao, Xiaolong, et al.
Publicado: (2016)

A Novel VHH Antibody Targeting the B Cell-Activating Factor for B-Cell Lymphoma
por: Wu, Wen, et al.
Publicado: (2014)

Development of an Anti-Idiotypic VHH Antibody and Toxin-Free Enzyme Immunoassay for Ochratoxin A in Cereals
por: Zhang, Caixia, et al.
Publicado: (2019)

Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies
por: Chen, Baohua, et al.
Publicado: (2022)

FULLY AI-DRIVEN HUMANOID VHH PHAGE LIBRARY
por: Zhao, Yangyang, et al.
Publicado: (2023)

Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine
por: Pille, Jan, et al.
Publicado: (2017)

A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
por: Schmidt, Diane J., et al.
Publicado: (2016)

Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform
por: Pekar, Lukas, et al.
Publicado: (2020)

Removal of a Conserved Disulfide Bond Does Not Compromise Mechanical Stability of a VHH Antibody Complex
por: Liu, Haipei, et al.
Publicado: (2019)

Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
por: Zhong, Weixiang, et al.
Publicado: (2022)

Development of VHH Antibodies against Dengue Virus Type 2 NS1 and Comparison with Monoclonal Antibodies for Use in Immunological Diagnosis
por: Fatima, Aneela, et al.
Publicado: (2014)

Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages
por: Hultberg, Anna, et al.
Publicado: (2007)

Peptide Linker Affecting the Activity Retention Rate of VHH in Immunosorbents
por: Li, Da, et al.
Publicado: (2020)

Increasing the melting temperature of VHH with the in silico free energy score
por: Tomimoto, Yusuke, et al.
Publicado: (2023)

The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent
por: Bachran, Christopher, et al.
Publicado: (2017)

The Availability of a Recombinant Anti-SNAP Antibody in VHH Format Amplifies the Application Flexibility of SNAP-Tagged Proteins
por: Aliprandi, Marisa, et al.
Publicado: (2010)

Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells
por: Lam, Kwok-Ho, et al.
Publicado: (2020)

Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library
por: Li, Qianlin, et al.
Publicado: (2022)

Rapid and Direct VHH and Target Identification by Staphylococcal Surface Display Libraries
por: Cavallari, Marco
Publicado: (2017)

Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure
por: De Genst, Erwin, et al.
Publicado: (2022)

VHH CDR-H3 conformation is determined by VH germline usage
por: Bahrami Dizicheh, Zahra, et al.
Publicado: (2023)

Single VHH-directed BCMA CAR-NK cells for multiple myeloma
por: Ren, Quan, et al.
Publicado: (2023)

Development and Utilization of Camelid VHH Antibodies from Alpaca for 2,2′,4,4′-Tetrabrominated Diphenyl Ether Detection
por: Bever, Candace R. S., et al.
Publicado: (2014)

Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants
por: Park, Se Ra, et al.
Publicado: (2020)

First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
por: Titong, Allison, et al.
Publicado: (2022)

Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor
por: Eliseev, Igor E., et al.
Publicado: (2018)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibe0akdu94oinrmsbt2hs0t7i0